Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.
about
HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin familyStrongyloides hyperinfection syndrome: an emerging global infectious diseaseType 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8+ cytotoxic T lymphocytes by free antigenic peptide.Laureate ESCI award for excellence in clinical science 1999. Cytokines and the human immunodeficiency virus: from bench to bedside. European Society for Clinical Investigation.Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES, macrophage inflammatory protein 1alpha) and cytokine (tumor necrosis factor alpha, interleukin-10 [IL-10], IL-1beta) production.Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?Multi-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS).Strongyloides stercoralis: Global Distribution and Risk FactorsDepression Correlates with Increased Plasma Levels of Inflammatory Cytokines and a Dysregulated Oxidant/Antioxidant Balance in HIV-1-Infected Subjects Undergoing Antiretroviral Therapy.Differences in humoral responses to the p24 antigen between Ethiopian and Swedish human immunodeficiency virus type 1-infected patients may suggest influences from a T-helper 2-like phenotype.Therapeutic role of CD8+ T cells in HIV-1 infection: targets and suppressors of viral replication.Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals.Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.Update on strongyloidiasis in the immunocompromised host.Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as to CD4 molecules on human T cellsAnalysis of the CD8+ T cell anti-HIV activity in heterologous cell co-cultures reveals the benefit of multiple HLA class I matches.Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progressionCharacterization of the phenotypic and lymphokine profile associated with strong CD8+ anti-HIV-1 suppressor activity (CASA).Cytokine profiles in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy.AIDS in Africa: a disaster no longer waiting to happen.Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens.Cytokines and chemokines in HIV infection: implications for therapy.An IL-15 dependent CD8 T cell response to selected HIV epitopes is related to viral control in early-treated HIV-infected subjects.Eosinophils from Physiology to Disease: A Comprehensive Review.Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients
P2860
Q28214202-9E823454-52A9-43E9-A4E2-B344A53E77FBQ28271599-9F030F58-E07D-4D0A-A9F5-9A2130F945EBQ30305830-6742B748-326A-4A5E-8929-5D52FDC24E40Q31775839-5546D105-F729-46F8-B759-184DCFF770CBQ33717470-C51F72BE-48CB-4670-9974-015546C6DA32Q33983556-F2CAA505-2B4B-492B-8173-D125FC7B2C93Q34007433-6FE48335-4E16-4766-B473-5AB80BE2E0ECQ34350857-7BD69E39-A6B8-4F18-928C-D1E84EF13F98Q34855113-C0B8ED72-E342-475A-9301-987620CBA5ECQ35064192-E16DE91A-66B6-42BF-8695-BC8CDD5F6402Q35231200-469EA0AC-1CD8-4120-B9E5-D1963D22B487Q36099451-8EEB4CDD-3BA4-4498-BCC8-7F455F8C527EQ36688376-28ABA2CB-7EBF-472A-BEE3-AE6D6B4E8E89Q37128257-9C8CC22B-6B6D-40C8-98FA-1D37C68333DCQ37838791-0D33E7CF-3081-46A9-BCF4-669B86FB2D9DQ39882387-7408F2CB-124E-4EA1-8904-50ADD891A06CQ40111950-1A3F8350-4A61-4647-812F-AC77BE540AA1Q40722440-587DDCB2-C0CA-4E5C-B9E3-4AB9E2545327Q40746493-8831BC09-182B-4FE0-ABAF-DF0EE00CD0CDQ41814325-DFFC5DF1-13C7-420E-8E9F-10A9BB0A5578Q42045726-442EBAEF-6FE3-4D90-94AC-A17B8384676FQ47712334-5B8C77D4-16CB-4969-A7FA-0CEBE7F7B7DCQ47912506-58A00982-78E3-4B36-9592-2E54D84BB17DQ51971392-B529EED1-2BE8-4C96-A50C-2A665676C0E5Q55311740-AABF92D0-C1FD-42AA-A84B-EB007B53F91BQ58659681-D9562DA9-D694-49F8-AC0A-9F4776ADC1A4
P2860
Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Effects of TH1 and TH2 cytokin ...... ations for long-term survival.
@ast
Effects of TH1 and TH2 cytokin ...... ations for long-term survival.
@en
type
label
Effects of TH1 and TH2 cytokin ...... ations for long-term survival.
@ast
Effects of TH1 and TH2 cytokin ...... ations for long-term survival.
@en
prefLabel
Effects of TH1 and TH2 cytokin ...... ations for long-term survival.
@ast
Effects of TH1 and TH2 cytokin ...... ations for long-term survival.
@en
P2093
P2860
P356
P1476
Effects of TH1 and TH2 cytokin ...... ations for long-term survival.
@en
P2093
P2860
P304
11135-11139
P356
10.1073/PNAS.92.24.11135
P407
P577
1995-11-01T00:00:00Z